Mantle cell lymphoma and Lung infiltration

Summary:

Lung infiltration is found among people with Mantle cell lymphoma, especially for people who are male, 60+ old.

The study analyzes which people have Lung infiltration with Mantle cell lymphoma. It is created by eHealthMe based on reports of 19 people who have Mantle cell lymphoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Mantle cell lymphoma?

Mantle cell lymphoma (cancer of lymphocytes, a type of white blood cell) is found to be associated with 115 drugs and 236 conditions by eHealthMe. Check the latest studies of Mantle cell lymphoma.

What is Lung infiltration?

Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung) is found to be associated with 1,196 drugs and 1,209 conditions by eHealthMe. Check the latest studies of Lung infiltration.



On Jul, 04, 2026

19 people who have Mantle Cell Lymphoma and Lung Infiltration are studied.

Would you have Lung infiltration when you have Mantle cell lymphoma?

Gender of people who have Mantle Cell Lymphoma and experienced Lung Infiltration *:

  • female: 27.78 %
  • male: 72.22 %

Age of people who have Mantle Cell Lymphoma and experienced Lung Infiltration *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 21.43 %
  • 60+: 78.57 %

Common co-existing conditions for these people *:

  1. Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 2 people, 10.53%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 10.53%
  3. Stress And Anxiety: 1 person, 5.26%
  4. Lymphoma (cancer that begins in immune system cells): 1 person, 5.26%
  5. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 5.26%
  6. High Blood Pressure: 1 person, 5.26%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.26%
  8. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 5.26%

Common drugs taken by these people *:

  1. Velcade: 5 people, 26.32%
  2. Protonix: 4 people, 21.05%
  3. Prilosec: 3 people, 15.79%
  4. Remeron: 3 people, 15.79%
  5. Vitamin D: 3 people, 15.79%
  6. Imbruvica: 3 people, 15.79%
  7. Flonase: 3 people, 15.79%
  8. Gemcitabine: 2 people, 10.53%
  9. Heparin: 2 people, 10.53%
  10. Pantoprazole: 2 people, 10.53%

Common symptoms for these people *:

  1. Cough: 8 people, 42.11%
  2. Fever: 8 people, 42.11%
  3. Pneumonia: 8 people, 42.11%
  4. Pleural Effusion (water on the lungs): 4 people, 21.05%
  5. Rashes (redness): 3 people, 15.79%
  6. Increased Tendency To Bruise (increased tendency to injure the underlying soft tissue or bone): 3 people, 15.79%
  7. Joint Pain: 3 people, 15.79%
  8. Loss Of Consciousness: 3 people, 15.79%
  9. Head Injury: 3 people, 15.79%
  10. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 3 people, 15.79%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Lung infiltration?

- Check whether Lung infiltration is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Lung infiltration:

All the conditions that are associated with Lung infiltration:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Lung infiltration and Mantle cell lymphoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: